Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Investing in Hard Times

Sep 01 2002

• By Deborah Erickson

Related Content

Starting Big

Nov 01 2001

Pitching Plenty to Many

May 01 2002

No Nonsense Drug Discovery

Jul 01 2002

The New Pharmaceutical Sciences

Apr 01 2002

Selling Structure

Mar 01 2001

IBM Dives into the Life Sciences

Jul 01 2001

Feeling No Pain

Apr 01 2002

Related Companies

Sirna Therapeutics

GSK plc

The Medicines Company

Intarcia Therapeutics, Inc.

Santarus, Inc.

Salmedix Inc.

Barrier Therapeutics

Johnson & Johnson

Johnson & Johnson

Avera Pharmaceuticals, Inc.

Pfizer Inc.

GSK plc

Biogen, Inc.

Incyte Corporation

Thermo Fisher Scientific

Celera Group

Revvity Inc.

Affymax, Inc.

Melinta Therapeutics, Inc.

Pfizer Inc.

Pfizer Inc.

Vertex Pharmaceuticals Incorporated

Vitae Pharmaceuticals, Inc.

Dassault Systemes BIOVIA Corp

Merck & Co., Inc.

Sanofi

Kemia Inc.

The Scripps Research Institute (TSRI)

Roche Holding AG

Exelixis, Inc.

Plexxikon, Inc.

Bristol Myers Squibb Company

Infinity Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

AVEO Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

Biogen, Inc.

Massachusetts Institute of Technology

Gilead Sciences, Inc.

Additional Topics

Strategy Business Strategies Platform Technologies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window